ERAS and pancreatic surgery: a review
Pancreatic surgery is still considered as a high-risk abdominal surgery. While the mortality rate is low, the morbidity remains high ranging from 30 to 60%. In 2012, the ERAS study group published the official recommendations to implement the enhanced recovery after surgery (ERAS) program in patients undergoing PD. Non-randomized studies have shown that ERAS was safe and feasible. They reported a significantly shortened LOS with lower morbidity in ERAS group. However, the level of evidence remains low due to absence of randomized study and because of a substantial heterogeneity in the content of ERAS protocols. Future studies should be prospective, multicentric and designed with a structured implementation of standardized ERAS pathway.
KeywordsEnhanced recovery after surgery ERAS Pancreatectomy Pancreatic surgery
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
The article is in accordance with ethical standards.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
For this type of study formal consent is not required.
- 4.Spanjersberg WR, Reurings J, Keus F, et al (2011) Fast track surgery versus conventional recovery strategies for colorectal surgery. Cochrane Database of System Rev (2):CD007635Google Scholar
- 6.Winter JM, Cameron JL, Campbell KA et al (2006) 1423 pan- creaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10(9):1199–1210 (discussion 1210–1211) Google Scholar
- 19.Kagedan DJ, Ahmed M, Devitt KS et al (2015) Enhanced recovery after pancreatic surgery: a systematic review of the evidence. HPB (Oxford) 17(1):11–16Google Scholar